RESEARCH SUPPORT, N.I.H., INTRAMURAL
Acupuncture for symptom management in patients with hyper-IgE (Job's) syndrome.
Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy 2011 January
OBJECTIVES: The objective of this study was to investigate the effects of acupuncture treatment for symptom management in patients with hyper-immunoglobulin E (IgE) syndrome (HIES).
DESIGN: This was a retrospective case series.
SETTING/LOCATION: The study was conducted at the The Clinical Research Center of the National Institutes of Health.
SUBJECTS: There were 8 adult patients with HIES ages 23-56 with varying symptoms in the study.
INTERVENTION: Acupuncture treatments were given from May 29, 2001 to February 17, 2009.
OUTCOME MEASURES: Acupuncture treatment efficacy was measured and evaluated using a 0-10 assessment instrument pre- and post-treatment.
RESULTS: The 8 patients with HIES suffered from a wide variety of symptoms related to the disease. Acupuncture treatments uniformly decreased the self-reported severity of symptoms.
CONCLUSIONS: This case series demonstrates that acupuncture is a clinically useful and safe therapy for symptom management in patients with HIES.
DESIGN: This was a retrospective case series.
SETTING/LOCATION: The study was conducted at the The Clinical Research Center of the National Institutes of Health.
SUBJECTS: There were 8 adult patients with HIES ages 23-56 with varying symptoms in the study.
INTERVENTION: Acupuncture treatments were given from May 29, 2001 to February 17, 2009.
OUTCOME MEASURES: Acupuncture treatment efficacy was measured and evaluated using a 0-10 assessment instrument pre- and post-treatment.
RESULTS: The 8 patients with HIES suffered from a wide variety of symptoms related to the disease. Acupuncture treatments uniformly decreased the self-reported severity of symptoms.
CONCLUSIONS: This case series demonstrates that acupuncture is a clinically useful and safe therapy for symptom management in patients with HIES.
Full text links
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app